PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 10 |
| 2008 | 30 |
| 2009 | 34 |
| 2010 | 39 |
| 2011 | 32 |
| 2012 | 43 |
| 2013 | 47 |
| 2014 | 34 |
| 2015 | 42 |
| 2016 | 38 |
| 2017 | 39 |
| 2018 | 36 |
| 2019 | 36 |
| 2020 | 78 |
| 2021 | 74 |
| 2022 | 47 |
| 2023 | 43 |
| 2024 | 42 |
| 2025 | 43 |
| 2026 | 43 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"j mol med berl"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations.
- Lebeda D, Smoljanow D, Hofhuis J, Thoms S.
- J Mol Med (Berl). 2026 Oct 22;104(1):123. doi: 10.1007/s00109-026-02728-z.
- PMCID: PMC13687240
Lebeda D, et al.J Mol Med (Berl). 2026.PMCID: PMC13687240 -
CTCF-FXN regulatory axis plays critical roles in clinical assessments and disease progression of primary open-angle glaucoma.
- Cai D, Yu Y, Ma J, Li T, Liu Z.
- J Mol Med (Berl). 2026 Sep 28;104(1):114. doi: 10.1007/s00109-026-02717-2.
- PMCID: PMC13619790
Cai D, et al.J Mol Med (Berl). 2026.PMCID: PMC13619790 -
The orofacial cleft risk gene IRF6 is a target gene of SOX9 in cranial neural crest cells.
- Weider M, Wagner MC, Schmid T, Gehlen-Breitbach S, Rodrian G, Peschel N, Schneider H, Ludwig KU, Wegner M, Gölz L.
- J Mol Med (Berl). 2026 Sep 26;104(1):113. doi: 10.1007/s00109-026-02720-7.
- PMCID: PMC13615914
Weider M, et al.J Mol Med (Berl). 2026.PMCID: PMC13615914 -
MicroRNA-122 as a regulator and biomarker of liver disease.
- Ahmadova S, Wicik Z, Mucha J, Palatini J, Ziętal K, Mirowska-Guzel D, Przybylkowski A, Eyileten C.
- J Mol Med (Berl). 2026 Sep 19;104(1):110. doi: 10.1007/s00109-026-02718-1.
- PMCID: PMC13588829
Ahmadova S, et al.J Mol Med (Berl). 2026.PMCID: PMC13588829 -
Regulation of pancreatic beta-cell mass and its importance for antidiabetic therapies.
- Lenzen S.
- J Mol Med (Berl). 2026 Sep 18;104(1):108. doi: 10.1007/s00109-026-02716-3.
- PMCID: PMC13586035
Lenzen S.J Mol Med (Berl). 2026.PMCID: PMC13586035 -
γδ T cells show distinct responses to CMV after stem cell transplantation.
- Sibbertsen F, Song Z, Ly C, Sandrock I, Bonn S, Koenecke C, Tan L, Schultze-Florey C, Prinz I.
- J Mol Med (Berl). 2026 Jul 20;104(1):96. doi: 10.1007/s00109-026-02703-8.
- PMCID: PMC13381381
Sibbertsen F, et al.J Mol Med (Berl). 2026.PMCID: PMC13381381 -
Beyond the target: implications of Wnt pathway inhibitors on bone health.
- Nachef C, Vanjak A, Haÿ E, Cohen-Solal M, Funck-Brentano T.
- J Mol Med (Berl). 2026 Jul 4;104(1):92. doi: 10.1007/s00109-026-02697-3.
- PMCID: PMC13331953
Nachef C, et al.J Mol Med (Berl). 2026.PMCID: PMC13331953 -
Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome.
- Ulutekin C, Can A, Súkeníková L, Querol L, Juntas-Morales R, Llauradó A, Dietmann A, Weiss T, Latorre D, Becher B, Ingelfinger F, Schreiner B.
- J Mol Med (Berl). 2026 Jul 4;104(1):93. doi: 10.1007/s00109-026-02698-2.
- PMCID: PMC13331871
Ulutekin C, et al.J Mol Med (Berl). 2026.PMCID: PMC13331871 -
Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families.
- Oziębło D, Leja ML, Gan N, Bałdyga N, Toliat MR, Budde BS, Skarżyński H, Ołdak M.
- J Mol Med (Berl). 2026 Jun 27;104(1):91. doi: 10.1007/s00109-026-02692-8.
- PMCID: PMC13314912
Oziębło D, et al.J Mol Med (Berl). 2026.PMCID: PMC13314912 -
Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.
- Jordan M, Stucki-Koch A, Schinke M, Willmer L, Senne I, Abbas N, Bentele M, Oldenkott D, Lachmann N, Feldbrügge L, Puffert R, Fangmann J, Ramm R, Thum T, Sewald K, Schmidt K, Fiedler J.
- J Mol Med (Berl). 2026 Jun 25;104(1):90. doi: 10.1007/s00109-026-02695-5.
- PMCID: PMC13294223
Jordan M, et al.J Mol Med (Berl). 2026.PMCID: PMC13294223